| Literature DB >> 30612937 |
Vita Droutman1, Feng Xue2, Emily Barkley-Levenson3, Hei Yeung Lam4, Antoine Bechara4, Benjamin Smith4, Zhong-Lin Lu5, Gue Xue6, Lynn C Miller4, Stephen J Read4.
Abstract
Neuroadaptations caused by chronic methamphetamine (MA) use are likely major contributors to high relapse rate following treatment. Thus, focusing intervention efforts at pre-empting addiction in vulnerable populations, thereby preventing MA-use-induced neurological changes that make recovery so challenging, may prove more effective than targeting chronic users. One approach is studying casual/recreational users, not diagnosed with substance use disorder. This group may be at high risk for addiction due to their experience with MA. On the other hand, they may be resilient against addiction since they were able to maintain casual use over the years and not become addicted. Understanding their neuro-cognitive characteristics during decision-making and risk-taking would help solve this dilemma and, may help identify intervention strategies. Unfortunately, research on neuro-cognitive characteristics of casual MA users is currently lacking. In this work we begin to address this deficit. This study was part of a larger investigation of neural correlates of risky sexual decision-making in men who have sex with men. While undergoing functional magnetic resonance imaging, 31 casual MA users and 66 non-users performed the CUPS task, in which they decided to accept or refuse a series of mixed gambles. Convergent results from whole brain, region of interest and psychophysiological interaction (PPI) analyses are presented. Whole brain analysis identified an amygdala-striatal cluster with weaker activation in casual MA users compared to non-users during decision-making. Activity in that cluster inversely correlated with decisions to gamble: lower activation corresponded to higher risk taking. Using this cluster as a seed in PPI analyses, we identified a wide range of neural network differences between casual MA users and non-users. Parametric whole brain analyses identified clusters in the ventral striatum, posterior insula and precuneus where activations modulated by risk and reward were significantly weaker in casual MA users than in non-users. The striatal cluster identified in these analyses overlapped with the amygdala-striatal cluster. This work identified neural differences in casual MA users' reward processing and outcome learning systems which may underlie their increased real-world risk-taking. It suggests that while making decisions casual MA users focus primarily on potential gain unlike non-users who also take the riskiness of the choice into consideration.Entities:
Keywords: Amygdala; Decision; Insula; Methamphetamine; Risk taking; Striatum; fMRI
Mesh:
Substances:
Year: 2018 PMID: 30612937 PMCID: PMC6411911 DOI: 10.1016/j.nicl.2018.101643
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Research participants substance use characteristics.
| % of participants used in last 90 days | Casual Meth-users | Non-users |
|---|---|---|
| Nicotine | 54.83 | 36.92 |
| Marijuana | 87.10 | 62.12 |
| All Other Drugs | 67.74 | 42.42 |
| Alcohol use, drinks per day* | 1.42 | 1.06 |
- Significant difference between the groups, p < .05
Fig. 1CUPS task.
Fig. 2Whole brain analysis, results of the decision phase where non-users' activation is higher than casual meth-users'.
Whole brain analysis results during evaluation phase where activation for non-users was higher than for meth-users. The value in the “max” column is the maximum z-stat in each local maxima. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. Cluster size is 260 voxels.
| Z-MAX X | Z-MAX Y | Z-MAX Z | Notes | |
|---|---|---|---|---|
| 3.91 | 12 | −2 | −16 | R Amygdala |
| 3.46 | 10 | 22 | 2 | R Caudate |
| 3.32 | 14 | 14 | −4 | R Caudate/Putamen |
| 2.98 | 12 | 8 | −14 | R Putamen |
| 2.83 | 18 | 8 | −16 | R Ventromedial Prefrontal Cortex (vmPFC) |
Fig. 3Psycho-physiological interaction analysis results during decision phase.
Psycho-physiological interaction analysis results during evaluation phase. Each row refers to activity related to one cluster. The value in the “max” column is the maximum z-stat in each cluster. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. The number of voxels in the cluster is recorded in the “voxels” column.
| Voxels | Z-MAX X | Z-MAX Y | Z-MAX Z | Notes | |
|---|---|---|---|---|---|
| All trials | Meth > NonMeth | ||||
| 3.27 | 132 | −18 | 46 | 16 | L Ventromedial Prefrontal Cortex (vmPFC) |
| All trials | NonMeth > Meth | ||||
| 3.96 | 700 | 66 | −26 | 8 | R Superior Temporal Gyrus/Posterior Insular Cortex (PIC) |
| 3.68 | 298 | 64 | −48 | 12 | R Middle Temporal Gyrus (MTG) |
| 3.80 | 104 | 52 | −72 | −16 | R Lateral Occipital Cortex |
| Safe trials | NonMeth > Meth | ||||
| 4.37 | 1713 | 36 | −24 | 10 | R PIC |
| 3.49 | 318 | 58 | −36 | −12 | R MTG |
| 4.81 | 253 | 52 | −68 | −16 | R Lateral Occipital Cortex |
| 3.85 | 179 | 56 | 32 | 16 | R Inferior Frontal Gyrus (IFG) |
| 4.07 | 126 | −46 | −38 | −18 | L Inferior Temporal Gyrus |
| 3.48 | 108 | −54 | −64 | −20 | L Lateral Occipital Cortex |
| 3.20 | 91 | 30 | 8 | 54 | R Medial Frontal Gyrus |
| 3.71 | 87 | 30 | −66 | 62 | R Lateral Occipital Cortex |
Fig. 4Psycho-physiological interaction analysis results during feedback phase.
Psycho-physiological interaction analysis results during feedback phase. Each row refers to activity related to one cluster. The value in the “max” column is the maximum z-stat in each cluster. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. The number of voxels in the cluster is recorded in the “voxels” column.
| Z-MAX | Voxels | Z-MAX X | Z-MAX Y | Z-MAX Z | Notes |
|---|---|---|---|---|---|
| All trials | NonMeth > Meth | ||||
| 4.21 | 714 | 52 | 32 | 2 | R Inferior Frontal Gyrus (IFG)/Ventrolateral Prefrontal Cortex (vlPFC) |
| 4.51 | 509 | −4 | 30 | −12 | L Ventromedial PFC |
| 3.35 | 320 | −30 | 48 | 32 | L Dorsolateral PFC |
| Safe trials | NonMeth > Meth | ||||
| 4.36 | 733 | 56 | −20 | 20 | R Posterior Insular Cortex |
| 3.90 | 292 | 52 | 32 | 4 | R IFG |
| 3.16 | 211 | −64 | −12 | 16 | L Postcentral Gyrus |
| 4.01 | 161 | −10 | 24 | −20 | L vmPFC |
| Risky trials | NonMeth > Meth | ||||
| 3.91 | 512 | 40 | 38 | −4 | R vlPFC, IFG |
| 4.15 | 404 | −4 | 30 | −12 | L vmPFC |
Parameters for model fit evaluation for post hoc logistical regression analysis.
| Model | AIC | BIC |
|---|---|---|
| Model1 - without interaction terms | 8344.3 | 8385.4 |
| Model2 - with interaction terms | 8238.5 | 8355.0 |
Model1 regresses decision to accept the gamble (risk) on group (cMU vs. NU), number of cups, potential gain and trial type. Model2 regresses decision to accept the gamble (risk) on group (cMU vs. NU), number of cups, potential gain, trial type and all interactions.
Results of logistical regression of decision to accept the gamble (risk) on potential gain, number of cups and EV category stratified by group.
| GROUP | METH | NON-USERS |
|---|---|---|
| Predictors | Estimate [95%CI]/z/p | Estimate [95%CI]/z/p |
| PayOff | 0.47 [0.10, 0.85]/2.37/0.02 | 0.30 [0.02, 0.56]/2.14/0.03 |
| NumCups | 0.06[−0.24, 0.38]/0.38/ns | −0.60 [−0.82, −0.39]/-5.37/<0.001 |
| Trial Type | 2.40 [0.99, 4.01]/2.96/0.003 | 2.05 [0.98, 3.15]/3.69/<0.001 |
Whole brain analysis with risk (number of cups) as parametric modulator during evaluation phase. Each row refers to activity related to one cluster. The value in the “max” column is the maximum z-stat in each cluster. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. The number of voxels in the cluster is recorded in the “voxels” column.
| Voxels | Z-MAX X | Z-MAX Y | Z-MAX Z | Notes | |
|---|---|---|---|---|---|
| Safe trials | NonMeth > Meth | ||||
| 3.72 | 157 | 6 | −38 | 46 | R Posterior Cingulate Cortex (PCC) |
| 3.37 | 140 | 10 | −54 | 18 | R Precuneus |
| 2.96 | 81 | −16 | −62 | 30 | L Precuneus |
| 2.94 | 68 | 4 | −78 | 32 | R Cuneal Cortex |
| 2.87 | 67 | 14 | 12 | −4 | R Caudate/Putamen |
| 3.25 | 64 | −46 | −16 | 10 | L Posterior Insular Cortex |
| Safe-Risky | NonMeth > Meth | ||||
| 3.70 | 98 | 14 | 12 | −4 | R Caudate/Putamen |
| 3.59 | 86 | 10 | −56 | 18 | R Precuneus |
| 3.48 | 74 | 14 | −14 | 6 | R Thalamus |
| 3.12 | 70 | 34 | −58 | 68 | R Superior Parietal Lobe |
This cluster is within amygdala-striatal ROI identified by whole brain analysis as differentiating cMU and NU during decision phase.
Whole brain analysis with gain (potential win amount) as parametric modulator during evaluation phase. Each row refers to activity related to one cluster. The value in the “max” column is the maximum z-stat in each cluster. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. The number of voxels in the cluster is recorded in the “voxels” column.
| Z-MAX | Voxels | Z-MAX X | Z-MAX Y | Z-MAX Z | Notes |
|---|---|---|---|---|---|
| All trials | NonMeth > Meth | ||||
| 3.6 | 264 | −58 | −18 | 14 | L Posterior Insular Cortex (PIC) |
| 3.3 | 124 | 4 | −78 | 36 | R Cuneal Cortex |
| 3.28 | 80 | −44 | −14 | 48 | L Precentral Gyrus |
| Safe trials | NonMeth > Meth | ||||
| 3.72 | 2521 | 12 | −88 | 4 | R Intracalcarine Cortex |
| 3.93 | 647 | −58 | −18 | 14 | L PIC |
| 4.49 | 403 | 6 | −40 | 46 | R Precuneus/Posterior Cingulate Cortex |
| 3.25 | 210 | 0 | 18 | 44 | Paracingulate Gyrus/Anterior Cingulate Cortex |
| 3.34 | 185 | 44 | 0 | 2 | R PIC |
| 3.75 | 184 | 48 | −10 | 52 | R Precentral Gyrus |
| 3.78 | 132 | 34 | −12 | 6 | R PIC |
| 3.11 | 128 | 6 | −12 | 2 | R Thalamus |
| 3.56 | 128 | 64 | −18 | 42 | R Supramarginal Gyrus |
| 3.71 | 125 | 34 | −4 | 54 | R Middle Frontal Gyrus (MFG) |
| 3.79 | 103 | 36 | −74 | 12 | R Lateral Occipital |
| 3.27 | 98 | −46 | −76 | 2 | L Lateral Occipital |
| 3.74 | 95 | 12 | 10 | 4 | R Caudate* |
| 3.83 | 89 | −22 | −64 | −10 | L Lingual Gyrus |
| 2.86 | 86 | −50 | 6 | 44 | L MFG |
| 3.43 | 86 | 30 | −58 | 60 | R Lateral Occipital |
| 3.91 | 75 | 18 | 2 | 74 | R Superior Frontal Gyrus |
| 2.96 | 72 | −42 | −4 | 4 | L PIC |
| 3.16 | 70 | −18 | −88 | 40 | L Lateral Occipital |
| 3.54 | 67 | 0 | −32 | 26 | Posterior Cingulate Cortex |
| 3.01 | 65 | −44 | −14 | 38 | L Precentral Gyrus |
| Safe - Risky | NonMeth > Meth | ||||
| 4.43 | 4109 | −12 | −78 | 50 | L Lateral Occipital |
| 3.81 | 840 | 20 | −90 | −6 | R Occipital Pole/Fusiform Gyrus |
| 4.21 | 323 | 4 | −40 | 46 | R Precuneus/Posterior Cingulate Cortex |
| 3.51 | 301 | −28 | −98 | −4 | L Occipital Pole |
| 3.57 | 283 | 16 | −58 | 24 | R Precuneus |
| 4.04 | 253 | 14 | −14 | 8 | R Thalamus |
| 3.62 | 230 | 36 | −2 | 54 | R MFG |
| 3.85 | 172 | −22 | −66 | −10 | L Occipital Fusiform Gyrus |
| 3.11 | 119 | 24 | 12 | −4 | R Putamen |
| 3.34 | 105 | −48 | −62 | −6 | L Lateral Occipital |
This cluster is within amygdala-striatal ROI identified by whole brain analysis as differentiating cMU and NU during decision phase.
Fig. 5Whole brain analysis with risk modulated regressors during decision phase.
Fig. 6Whole brain analysis with reward modulated regressors during decision phase.
Meth-use index whole brain analysis results during decision phase where more intense use corresponds to weaker activation. The value in the “max” column is the maximum z-stat in each local maxima. X, Y, and Z are x, y, and z coordinates in MNI-152 space in mm. Cluster size is 160 voxels.
| Z-MAX | Z-MAX X | Z-MAX Y | Z-MAX Z | Notes |
|---|---|---|---|---|
| 3.35 | −22 | 16 | 10 | L Putamen |
| 3.05 | −14 | 20 | 12 | L Caudate |
| 2.96 | −10 | 18 | 14 | L Caudate |
| 2.75 | −10 | 24 | 8 | L Caudate |
| 2.62 | −8 | 10 | 4 | L Caudate |
| 2.49 | −14 | 32 | 20 | L Paracingulate Gyrus/Anterior Cingulate Gyrus |
Fig. 7Meth-use index correlational analysis results (across all subjects) during decision phase.
Fig. 8Combined results of 3 whole brain analyses during decision phase where activation in non-users was greater that in casual meth-users, from Fig. 2, Fig. 5, Fig. 6) identifying the overlapping areas: (1) - All trials contrasted with baseline, (2) – risk-modulated activation in safe trials contrasted with risky trials, (3) – reward-modulated activation in safe trials contrasted with risky trials.